Immediate Impact

49 standout
Sub-graph 1 of 24

Citing Papers

Cancer statistics, 2024
2024 Standout
Myeloid-derived suppressor cells in cancer and cancer therapy
2024 Standout
2 intermediate papers

Works of Armin Leitner being referenced

Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid Leukemia
2011

Author Peers

Author Last Decade Papers Cites
Armin Leitner 300 337 207 13 446
Clementina Caracciolo 321 411 200 12 499
K. F. Vykoupil 227 258 111 14 396
Ekkehard Eigendorff 188 223 89 19 408
F. Ferrara 220 300 96 17 387
Amity Frede 318 384 169 13 459
J. Janssen 209 268 107 11 389
Alfonso Quintás-Cardama 261 300 181 17 404
Dorthe Rønnov‐Jessen 155 282 78 14 449
J Score 178 222 214 12 385
Erika M. Mosesón 247 325 181 10 467

All Works

Loading papers...

Rankless by CCL
2026